HYMAN CHARLES D Vertex Pharmaceuticals Incorporated Transaction History

HYMAN CHARLES D portfolio value:

$232,000
portfolio value

HYMAN CHARLES D quarter portfolio value change:

+2.75%
quarter

Vertex Pharmaceuticals Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 7K $289.54 800
Q2 2022 share Increase 0.00% 800 shares 225K $281.79 800